These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 15692073)

  • 1. Strategy for distribution of influenza vaccine to high-risk groups and children.
    Longini IM; Halloran ME
    Am J Epidemiol; 2005 Feb; 161(4):303-6. PubMed ID: 15692073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of influenza: recommendations for influenza immunization of children, 2007-2008.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2008 Apr; 121(4):e1016-31. PubMed ID: 18381500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Universal influenza vaccination in the United States: are we ready? Report of a meeting.
    Schwartz B; Hinman A; Abramson J; Strikas RA; Allred N; Uyeki T; Orenstein W
    J Infect Dis; 2006 Nov; 194 Suppl 2():S147-54. PubMed ID: 17163388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Universal influenza vaccination and live attenuated influenza vaccination of children.
    Glezen WP
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S104-9. PubMed ID: 18820568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal allocation of pandemic influenza vaccine depends on age, risk and timing.
    Mylius SD; Hagenaars TJ; Lugnér AK; Wallinga J
    Vaccine; 2008 Jul; 26(29-30):3742-9. PubMed ID: 18524428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
    Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP
    Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing influenza vaccine distribution.
    Medlock J; Galvani AP
    Science; 2009 Sep; 325(5948):1705-8. PubMed ID: 19696313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Summary recommendations by the Advisory Committee on Immunization Practices (ACIP) for the use of H1N1 influenza vaccine for the 2009-2010 vaccination season.
    Litchfield SM
    AAOHN J; 2009 Sep; 57(9):354. PubMed ID: 19842610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and treatment of influenza in high-risk groups: children, pregnant women, immunocompromised hosts, and nursing home residents.
    Whitley RJ; Monto AS
    J Infect Dis; 2006 Nov; 194 Suppl 2():S133-8. PubMed ID: 17163386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experiences with obtaining influenza vaccination among persons in priority groups during a vaccine shortage--United States, October-November, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Dec; 53(49):1153-5. PubMed ID: 15614228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High influenza vaccination coverage in children with high-risk conditions during a vaccine shortage.
    Allison MA; Daley MF; Barrow J; Crane LA; Beaty BL; Allred N; Kempe A
    Arch Pediatr Adolesc Med; 2009 May; 163(5):426-31. PubMed ID: 19414688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The time has come to change the influenza vaccination strategy].
    Kiro A; Mor Z
    Harefuah; 2008 Dec; 147(12):993-4, 1028. PubMed ID: 19260598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of influenza vaccination in working-age cancer patients.
    Avritscher EB; Cooksley CD; Geraci JM; Bekele BN; Cantor SB; Rolston KV; Elting LS
    Cancer; 2007 Jun; 109(11):2357-64. PubMed ID: 17457827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Nov; 58(44):1241-5. PubMed ID: 19910912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of inactivated trivalent influenza vaccine to parents of high-risk infants in the neonatal intensive care unit.
    Shah SI; Caprio M; Hendricks-Munoz K
    Pediatrics; 2007 Sep; 120(3):e617-21. PubMed ID: 17766502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimated influenza vaccination coverage among adults and children--United States, September 1, 2004-January 31, 2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Apr; 54(12):304-7. PubMed ID: 15800475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza vaccination coverage among children aged 6 months--18 years - eight immunization information system sentinel sites, United States, 2008-09 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(38):1059-62. PubMed ID: 19798018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. State-specific influenza vaccination coverage among adults--United States, 2006-07 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Sep; 57(38):1033-9. PubMed ID: 18818582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on influenza A (H1N1) 2009 monovalent vaccines.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(39):1100-1. PubMed ID: 19816398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.